SAN DIEGO, Jan. 9 /PRNewswire/ -- Neurocrine Biosciences, Inc.
(Nasdaq: NBIX) announced today that the Company will be presenting at the
JPMorgan H&Q 20th Annual Healthcare Conference being held in San Francisco on
Thursday, January 10, 2002 at 12:00PM Pacific Time (3:00PM Eastern Time). The
presentation will be simultaneously Webcast and can be viewed through a link
provided via the JPMorgan H&Q website at
Gary Lyons, President and CEO of Neurocrine will discuss the Company's
insomnia program as well as highlighting the Company's pipeline. If you are
unable to attend the Webcast and would like further information on this
announcement please contact the Investor Relations Department at Neurocrine
Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster.
The presentation will be archived for 30 days.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company
focused on neurological and endocrine diseases and disorders. Our product
candidates address some of the largest pharmaceutical markets in the world
including insomnia, anxiety, depression, malignant brain tumors and peripheral
cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating
disorders, pain, stroke, and certain female health disorders.
Neurocrine Biosciences, Inc. news releases are available through the
Company's website via the Internet at http://www.neurocrine.com .
Contact: Claudia Jones at 858-658-7600.
MAKE YOUR OPINION COUNT - Click Here
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Paul Hawran of Neurocrine Biosciences, Inc., +1-858-658-7600